Skip to main content
Erschienen in: Familial Cancer 3/2010

01.09.2010

Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study

verfasst von: Andrea Vodermaier, Mary Jane Esplen, Christine Maheu

Erschienen in: Familial Cancer | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Little is known about protective and vulnerability factors of long-term adjustment with BRCA1/2 carrier status. Specifically, the role of personal resources and perceptions of stigmatization have not been studied in the context of adjustment with hereditary breast cancer. The present study, therefore, explored associations of personal resources and stigma with cancer-specific anxiety in female BRCA1/2-carriers within a cross-sectional multi-center study. Participants (n = 237) had received carrier notification between 4 months and 8 years before data collection and experienced a low level of cancer-related anxiety on average. Younger age was associated with both higher perceptions of stigma (P = .002) and cancer-specific anxiety (P = .034). Time since receiving test results, affected status, having undergone prophylactic mastectomy or prophylactic oophorectomy was not associated with demographic or psychological variables. Global self-esteem (P = .002) and mastery (P < .001) were associated with fewer intrusive and avoidant thoughts, whereas stigma was associated with more (P < .001). Time since test result receipt did not moderate relations of self-esteem, mastery or stigma and cancer-specific anxiety. Cancer-specific anxiety did not vary as a function of time since carrier notification. Hence cancer-specific distress may be explained by past and ongoing experiences of cancer in the family rather than by the time point of carrier notification. Psychological interventions may benefit from specifically addressing feelings of stigmatization, and promoting self-worth and personal control in order to affect cancer-specific anxiety.
Literatur
1.
Zurück zum Zitat Mosher CE, Danoff-Burg S (2005) Psychosocial impact of parental cancer in adulthood: a conceptual and empirical review. Clin Psychol Rev 25:365–382CrossRefPubMed Mosher CE, Danoff-Burg S (2005) Psychosocial impact of parental cancer in adulthood: a conceptual and empirical review. Clin Psychol Rev 25:365–382CrossRefPubMed
2.
Zurück zum Zitat Van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C et al (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21:3867–3874CrossRefPubMed Van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C et al (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21:3867–3874CrossRefPubMed
3.
Zurück zum Zitat Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG, Psychosocial Study Collaborators (2007) Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 96(5):718–724CrossRefPubMed Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG, Psychosocial Study Collaborators (2007) Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 96(5):718–724CrossRefPubMed
4.
Zurück zum Zitat Reichelt JG, Heimdal K, Moeller P, Dahl AA (2004) BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 3:21–28CrossRefPubMed Reichelt JG, Heimdal K, Moeller P, Dahl AA (2004) BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 3:21–28CrossRefPubMed
5.
Zurück zum Zitat Taylor SE (1983) Adjustment to threatenting events: a theory of cognitive adaptation. Am Psychol 38(11):1161–1173CrossRef Taylor SE (1983) Adjustment to threatenting events: a theory of cognitive adaptation. Am Psychol 38(11):1161–1173CrossRef
6.
Zurück zum Zitat Carver CS, Scheier MF, Weintraub JK (1989) Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 56:267–283CrossRefPubMed Carver CS, Scheier MF, Weintraub JK (1989) Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 56:267–283CrossRefPubMed
7.
Zurück zum Zitat Kash KM, Holland JC, Halper MS, Miller DG (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24–30CrossRefPubMed Kash KM, Holland JC, Halper MS, Miller DG (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24–30CrossRefPubMed
8.
Zurück zum Zitat Meiser B, Butow P, Barratt A, Friedlander M, Kirk J, Gaff C et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111CrossRefPubMed Meiser B, Butow P, Barratt A, Friedlander M, Kirk J, Gaff C et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111CrossRefPubMed
9.
Zurück zum Zitat Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD et al (2002) A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 21:564–572CrossRefPubMed Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD et al (2002) A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 21:564–572CrossRefPubMed
10.
Zurück zum Zitat Kenen R, Ardern-Jones A, Eeles R (2006) “Social separation” among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation. J Genet Couns 15:149–162CrossRefPubMed Kenen R, Ardern-Jones A, Eeles R (2006) “Social separation” among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation. J Genet Couns 15:149–162CrossRefPubMed
11.
Zurück zum Zitat Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR (2004) Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 13:733–740CrossRefPubMed Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR (2004) Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 13:733–740CrossRefPubMed
12.
Zurück zum Zitat McConkie-Rosell A, DeVillis BJ (2000) Threat to parental role: a possible mechanism of altered self-concept related to carrier knowledge. J Genet Couns 9:285–302CrossRef McConkie-Rosell A, DeVillis BJ (2000) Threat to parental role: a possible mechanism of altered self-concept related to carrier knowledge. J Genet Couns 9:285–302CrossRef
13.
Zurück zum Zitat Fortenberry JD, McFarlane M, Bleakley A, Bull S, Fishbein M, Grimley DM, Malotte CK, Stoner BP (2002) Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health 92(3):378–381CrossRefPubMed Fortenberry JD, McFarlane M, Bleakley A, Bull S, Fishbein M, Grimley DM, Malotte CK, Stoner BP (2002) Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health 92(3):378–381CrossRefPubMed
14.
Zurück zum Zitat Major B, O’Brien LT (2005) The social psychology of stigma. Ann Rev Psychol 56:393–421CrossRef Major B, O’Brien LT (2005) The social psychology of stigma. Ann Rev Psychol 56:393–421CrossRef
15.
Zurück zum Zitat McCaulay M, Mintz L, Glenn AA (1988) Body image, self-esteem, and depression-proneness: closing the gender gap. Sex Roles 18:381–391CrossRef McCaulay M, Mintz L, Glenn AA (1988) Body image, self-esteem, and depression-proneness: closing the gender gap. Sex Roles 18:381–391CrossRef
16.
Zurück zum Zitat Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6(6):546–552CrossRefPubMed Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6(6):546–552CrossRefPubMed
17.
Zurück zum Zitat Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ (2000) Women’s regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7(2):150–154CrossRefPubMed Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ (2000) Women’s regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7(2):150–154CrossRefPubMed
18.
Zurück zum Zitat Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324CrossRefPubMed Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324CrossRefPubMed
19.
Zurück zum Zitat Sankar P, Cho MK, Wolpe PR, Schairer C (2006) What is in a cause? Exploring the relationship between genetic cause and felt stigma. Genet Med 8(1):33–42CrossRefPubMed Sankar P, Cho MK, Wolpe PR, Schairer C (2006) What is in a cause? Exploring the relationship between genetic cause and felt stigma. Genet Med 8(1):33–42CrossRefPubMed
20.
Zurück zum Zitat Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, et al. (2009) The BRCA self-concept scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology 18(11):1216–1229 Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, et al. (2009) The BRCA self-concept scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology 18(11):1216–1229
21.
Zurück zum Zitat Rosenberg M (1965) Society and the adolescent self image. Princeton University Press, Princeton, New Jersey Rosenberg M (1965) Society and the adolescent self image. Princeton University Press, Princeton, New Jersey
22.
Zurück zum Zitat Rosenberg M (1979) Conceiving the self. Basic Books, New York Rosenberg M (1979) Conceiving the self. Basic Books, New York
23.
Zurück zum Zitat Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218PubMed
24.
Zurück zum Zitat Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 10:459–468CrossRefPubMed Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 10:459–468CrossRefPubMed
25.
Zurück zum Zitat Stefanek M, Hartmann L, Nelson W (2001) Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 93(17):1297–1306CrossRefPubMed Stefanek M, Hartmann L, Nelson W (2001) Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 93(17):1297–1306CrossRefPubMed
26.
Zurück zum Zitat Dowdy SC, Stefanek M, Hartmann LC (2004) Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol 191(4):1113–1123CrossRefPubMed Dowdy SC, Stefanek M, Hartmann LC (2004) Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol 191(4):1113–1123CrossRefPubMed
27.
Zurück zum Zitat Hatcher MB, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semi-structured interviews. BMJ 322:1–7CrossRef Hatcher MB, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semi-structured interviews. BMJ 322:1–7CrossRef
28.
Zurück zum Zitat Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, Borgen P, Holland J, Kash K et al (1997) Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 19(4):362–369CrossRefPubMed Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, Borgen P, Holland J, Kash K et al (1997) Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 19(4):362–369CrossRefPubMed
29.
Zurück zum Zitat Erblich J, Bovbjerg DH, Valdimarsdottir HB (2000) Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 22(1):53–59CrossRefPubMed Erblich J, Bovbjerg DH, Valdimarsdottir HB (2000) Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 22(1):53–59CrossRefPubMed
Metadaten
Titel
Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study
verfasst von
Andrea Vodermaier
Mary Jane Esplen
Christine Maheu
Publikationsdatum
01.09.2010
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 3/2010
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9325-x

Weitere Artikel der Ausgabe 3/2010

Familial Cancer 3/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.